Learn more

UNIV AUSTRALIAN

Overview
  • Total Patents
    996
  • GoodIP Patent Rank
    84,576
About

UNIV AUSTRALIAN has a total of 996 patent applications. Its first patent ever was published in 1961. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are FENG WEIJIAN, GOINO TADASHI and RUTGERS THE STATE UNIVERSITY OF NEW JERSEY.

Patent filings per year

Chart showing UNIV AUSTRALIANs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Parish Christopher Richard 93
#2 Cowden William Butler 47
#3 Ninham Barry William 31
#4 Freeman Craig Geoffrey 31
#5 Senden Timothy John 28
#6 Ringwood Alfred Edward 28
#7 Pashley Richard Mark 26
#8 Calka Andrzej 24
#9 Stephens Ross Wentworth 22
#10 Luther-Davies Barry 22

Latest patents

Publication Filing date Title
WO2016033650A1 Markers of disease susceptibility and onset and uses therefor
WO2016011479A1 Planar sensor array
WO2015179894A1 An optical parametric generator
WO2015143481A1 Film
WO2014078909A1 Clustered volley method and apparatus
WO2015027269A1 Photovoltaic device with selective emitter structure and method of producing same
SG11201408101TA Vaccination with interleukin-4 antagonists
EP2802215A1 Method for modulating plant root architecture
WO2013102238A1 Optical phased array
CN103958414A Giant dielectric constant material
CN103827023A Exfoliating laminar material by ultrasonication in surfactant
NZ611316A Histone inhibition
WO2012024738A1 Mirror panels for large area solar concentrators
WO2012024736A1 A semiconductor manufacturing process and a semiconductor article
WO2011109874A1 Inhibition of glutathione transferase zeta
CA2792610A1 Heparan sulfate replacement therapy
CA2783485A1 A computed tomography imaging process and system
WO2011041839A1 Udp-galactopyranose mutase from haemonchus contortus, and rnai agents that inhibit it
WO2011003138A1 Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor
WO2010138999A1 Plasma etching of chalcogenides